FDA NDC Directory · JSON-LD · Markdown

CABERGOLINE

NDC 27808-315 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerCranbury Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA220309
Dosage form / routeTABLET · ORAL
Active ingredientsCABERGOLINE (.5 mg/1)
Marketing started20260801
Package count1

External sources

Source: openFDA. Public-domain (CC0).